These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30879022)

  • 1. Misclassification of Myocardial Injury as Myocardial Infarction: Implications for Assessing Outcomes in Value-Based Programs.
    McCarthy C; Murphy S; Cohen JA; Rehman S; Jones-O'Connor M; Olshan DS; Singh A; Vaduganathan M; Januzzi JL; Wasfy JH
    JAMA Cardiol; 2019 May; 4(5):460-464. PubMed ID: 30879022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims Data.
    Wasfy JH; Price M; Normand ST; Januzzi JL; McCarthy CP; Hsu J
    Circ Cardiovasc Qual Outcomes; 2024 Feb; 17(2):e009986. PubMed ID: 38240159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-based differences in clinical outcomes and resource utilization of type 2 myocardial infarction.
    Ariss RW; Elzanaty AM; Minhas AMK; Nazir S; Gul S; Patel N; Ahuja KR; Mochon A; Eltahawy EA
    Int J Cardiol; 2021 Sep; 338():24-29. PubMed ID: 34058288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of objective evidence of myocardial ischemia to facilitate the diagnostic and prognostic distinction between type 2 myocardial infarction and myocardial injury.
    Sandoval Y; Smith SW; Sexter A; Schulz K; Apple FS
    Eur Heart J Acute Cardiovasc Care; 2020 Feb; 9(1):62-69. PubMed ID: 29979092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort.
    Raphael CE; Roger VL; Sandoval Y; Singh M; Bell M; Lerman A; Rihal CS; Gersh BJ; Lewis B; Lennon RJ; Jaffe AS; Gulati R
    Circulation; 2020 Feb; 141(6):454-463. PubMed ID: 31902228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wake Forest University long-term follow-up of type 2 myocardial infarction: The Wake-Up T2MI Registry.
    Jogu HR; Arora S; Vaduganathan M; Qamar A; Pandey A; Chevli PA; Pansuriya TH; Ahmad MI; Dutta A; Sunkara PR; Qureshi W; Vasu S; Upadhya B; Bhatt DL; Januzzi JL; Herrington D
    Clin Cardiol; 2019 Jun; 42(6):592-604. PubMed ID: 30941774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 Myocardial Infarction in a Sub-Saharan Africa Population: Challenging the Current Concepts-Data From REACTIV.
    Yao H; Touré C; Ekou A; Sepih E; Cottin Y; Zeller M; Putot A; N'Guetta R
    J Am Heart Assoc; 2024 Jul; 13(14):e032149. PubMed ID: 38979833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 myocardial infarction: incidence, presentation, treatment and outcome in routine clinical practice.
    Radovanovic D; Pilgrim T; Seifert B; Urban P; Pedrazzini G; Erne P
    J Cardiovasc Med (Hagerstown); 2017 May; 18(5):341-347. PubMed ID: 28107211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study.
    Greenslade JH; Adikari T; Mueller C; Sandoval Y; Nestelberger T; Parsonage W; Hawkins T; Cullen L
    Emerg Med J; 2018 Mar; 35(3):169-175. PubMed ID: 28784608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordance between ICD-Coded Myocardial Infarction and Diagnosis according to the Universal Definition of Myocardial Infarction.
    Díaz-Garzón J; Sandoval Y; Smith SW; Love S; Schulz K; Thordsen SE; Johnson BK; Driver B; Jacoby K; Carlson MD; Dodd KW; Moore J; Scott NL; Bruen CA; Hatch R; Apple FS
    Clin Chem; 2017 Jan; 63(1):415-419. PubMed ID: 27811209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnet Hospitals and 30-Day Readmission and Mortality Rates for Medicare Beneficiaries.
    Hamadi HY; Martinez D; Palenzuela J; Spaulding AC
    Med Care; 2021 Jan; 59(1):6-12. PubMed ID: 32925454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of Type 2 Myocardial Infarction and Readmission With Type 1 Myocardial Infarction in Hypertensive Crises (from a Nationwide Analysis).
    Maraey A; Elzanaty AM; Salem M; Khalil M; Elsharnoby H; Younes A; Elsharnouby M; Nazir S; Elgendy IY; Siragy HM
    Am J Cardiol; 2021 Dec; 161():56-62. PubMed ID: 34794619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
    Gaggin HK; Liu Y; Lyass A; van Kimmenade RR; Motiwala SR; Kelly NP; Mallick A; Gandhi PU; Ibrahim NE; Simon ML; Bhardwaj A; Belcher AM; Harisiades JE; Massaro JM; D'Agostino RB; Januzzi JL
    Circulation; 2017 Jan; 135(2):116-127. PubMed ID: 27881568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis.
    Vargas KG; Haller PM; Jäger B; Tscharre M; Binder RK; Mueller C; Lindahl B; Huber K
    Clin Res Cardiol; 2019 Jul; 108(7):749-762. PubMed ID: 30535801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS).
    Feinstein MJ; Nance RM; Delaney JAC; Heckbert SR; Budoff MJ; Drozd DR; Burkholder GA; Willig JH; Mugavero MJ; Mathews WC; Moore RD; Eron JJ; Napravnik S; Hunt PW; Geng E; Hsue P; Peter I; Lober WB; Crothers K; Grunfeld C; Saag MS; Kitahata MM; Lloyd-Jones DM; Crane HM
    BMC Med; 2019 Jul; 17(1):149. PubMed ID: 31362721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk Factors.
    Nance RM; Crane HM; Ritchings C; Rosenblatt L; Budoff M; Heckbert SR; Drozd DR; Mathews WC; Geng E; Hunt PW; Feinstein MJ; Moore RD; Hsue P; Eron JJ; Burkholder GA; Rodriguez B; Mugavero MJ; Saag MS; Kitahata MM; Delaney JAC
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):916-921. PubMed ID: 29984593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines.
    Pandey A; Golwala H; Hall HM; Wang TY; Lu D; Xian Y; Chiswell K; Joynt KE; Goyal A; Das SR; Kumbhani D; Julien H; Fonarow GC; de Lemos JA
    JAMA Cardiol; 2017 Jul; 2(7):723-731. PubMed ID: 28445559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design.
    Lambrakis K; French JK; Scott IA; Briffa T; Brieger D; Farkouh ME; White H; Chuang AM; Tiver K; Quinn S; Kaambwa B; Horsfall M; Morton E; Chew DP
    Am Heart J; 2019 Feb; 208():11-20. PubMed ID: 30522086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute versus chronic myocardial injury and long-term outcomes.
    Kadesjö E; Roos A; Siddiqui A; Desta L; Lundbäck M; Holzmann MJ
    Heart; 2019 Dec; 105(24):1905-1912. PubMed ID: 31337668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of Misclassification of Type 2 Myocardial Infarction on Clinical Outcomes.
    Hawatmeh A; Thawabi M; Aggarwal R; Abirami C; Vavilin I; Wasty N; Visveswaran G; Cohen M
    Cardiovasc Revasc Med; 2020 Feb; 21(2):176-179. PubMed ID: 31078438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.